CA9 and neoplasm: Tumors were harvested at the end of treatment and examined for the expression of CA9. As seen in our in vitro studies, HT1080 xenografts exposed to metronomic Dox had significantly lower expression of CA9 (Fig. 5d), and only combination therapy induced significant tumor necrosis (Fig. 5e).